(Q44076958)

29 November 2017

title

Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey (English)

1 reference

29 November 2017

1 reference

Mathias Leblanc

1

1 reference

29 November 2017

Claude Labrie

2

1 reference

29 November 2017

Alain Bélanger

3

1 reference

29 November 2017

Bernard Candas

4

1 reference

29 November 2017

Fernand Labrie

5

1 reference

29 November 2017

language of work or name

1 reference

1 June 2002

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

29 November 2017

published in

1 reference

29 November 2017

volume

81

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

159-164

1 reference

The actions of exogenous dehydroepiandrosterone in experimental animals and humans

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Neurosteroids: a new function in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Dehydroepiandrosterone (DHEA) treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Oral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Dehydroepiandrosterone replacement in women with adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Replacement of DHEA in aging men and women. Potential remedial effects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and nonoral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

Metabolism of dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900059-6

7 January 2021

10.1016/S0960-0760(02)00059-6

Identifiers

DOI

1 reference

29 November 2017

1 reference